ED vs GTBP · P/E 18, rev $16.92B vs $17.4M cap
Consolidated Edison Inc (ED) versus GT Biopharma Inc (GTBP) — a side-by-side from cached financials, not a winner call.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
GT Biopharma Inc (GTBP) is a biotechnology company listed on NASDAQ.
Latest reported ED revenue for 2025-12-31 was $16.92B. Net income was $2.02B. Revenue was up 10.9% from 2024-12-31 to 2025-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
GTBP does not have a complete income-statement cache yet.
ED currently screens at market cap $36.02B and trailing P/E 18.3. GTBP currently screens at market cap $17.4M.
Not investment advice. Open the ED and GTBP stock pages for the full models.
Not investment advice.